India Pesticides Limited (IPL), one of the fastest growing agro-chemical companies for technical manufacturing, has announced its unaudited consolidated financial results for the quarter ending 30th June 2025.

India Pesticides has reported net profit of Rs. 35 crore as compared to Rs. 19 crore in Q1 FY25, reflecting a growth of 79.2 per cent. PAT stood at Rs. 22 crore, with PAT margin at 12.3 per cent, reflecting robust bottom-line execution.

Q1 FY26 revenue stood at Rs.282 crore as compared to Rs. 224 crore in Q1 FY25, reflecting a growth of 25.8 per cent  YoY and 33.9 per cent QoQ, driven by strong volume traction and improved pricing, alongside a sharp uptick in profitability.

EBITDA margin expanded by 417 bps YoY, supported by price recovery in Herbicides and Intermediates and higher operating leverage. Technical & API segments contributed 71 per cent to total revenue, underscoring the strength of our diversified product portfolio.

During the quarter, India Pesticides commissioned expanded PEDA capacity from 2,000 MT to 6,000 MT per annum; further scale-up to 8,500 MT on track for Q2 FY26.

The company also invested Rs. 29.5 crore, fully funded through internal accruals, reinforces backward integration, boosts operational efficiency, and supports import substitution in line with the Aatma Nirbhar Bharat initiative. The company also commissioned the expansion of formulation plant by enhancement 3,500 MT.

Commenting on the performance, Anand S. Agarwal, Director, Founder & Promoter said: “We have commenced FY26 with a robust performance, marked by strong execution and strategic discipline, resulting revenue growth of 25.8% YoY and 33.9% sequentially. This growth was primarily driven by strong volume growth of 16% and price improvement of 8%.

With recovery in prices, & along with higher operating leverage, EBITDA margin expanded by 417 bps YoY and 176 bps QoQ to 18.4%. We expect the margins to remain in a similar range going ahead. This performance reflects the success of our strategic framework, which emphasizes profitable growth, a sharper focus on backward integration, and sustained margin improvement. We continue to strengthen our position as a leading producer of India’s top-selling rice herbicides and their key intermediates, supported by a fully integrated value chain and ongoing capacity expansion.

In line with this, we successfully commissioned the expanded PEDA intermediate facility during the quarter, increasing capacity from 2,000 MT to 6,000 MT per annum, completed with a capital outlay of Rs. 29.5 crore funded through internal accruals, marks a critical step in our backward integration efforts for Pretilachlor Technical. The next expansion phase, targeting 8,500 MT annual capacity, is on track for completion by Q2 FY26. This initiative strengthens supply chain resilience and supports our long-term goal of building self-reliant manufacturing infrastructure, in alignment with the Government’s Aatma Nirbhar Bharat programme. 

Looking ahead, we expect growth momentum to continue, supported by favorable macro tailwinds such as a strong monsoon forecast, recovery in export market and stable input costs. With a strong product pipeline, expanding premium portfolio, and improving operational efficiencies, we are well-positioned to deliver steady EBITDA growth and stable gross margins. We remain committed to creating long-term value for our stakeholders while contributing positively to the environment and society. Backed by a resilient foundation and a focused strategic vision, we are confident in our ability to navigate the future with strength and purpose.”